Comparison of MRI and prognostic features of intrahepatic cholangiocarcinoma between patients with and without hepatitis B virus infection
摘要
To compare the clinical, MRI, and prognostic features of intrahepatic cholangiocarcinoma (ICCA) between patients with and without hepatitis B virus (HBV) infection.
MethodsWe retrospectively analyzed 211 patients with ICCA who underwent preoperative MRI and curative-intent surgical resection between 2015 and 2018. Two radiologists independently reviewed MRI features. Clinicopathologic and MRI characteristics were compared according to HBV status. Recurrence-free survival (RFS) and overall survival (OS) were assessed using the Kaplan-Meier method and log-rank test. Recurrence rates were compared according to tumor site, and logistic regression analysis was used to identify independent predictors of intrahepatic recurrence.
ResultsAmong the 211 patients (mean age, 63.4 ± 10.5 years; 126 men), 81 (38.4%) were HBV-positive and 130 (61.6%) were HBV-negative. The purely mass-forming type of ICCA was more common in the HBV-positive group (91.4% vs. 76.9%; p = 0.007), whereas combined types were more frequent in the HBV-negative group. On MRI, peripheral tumor location was more frequent in the HBV-positive group (55.5% vs. 34.6%; p = 0.011), while bile duct invasion/dilatation (p < 0.001), secondary confluence involvement (p = 0.005), and periductal tumor infiltration (p = 0.030) were less common. Rim or non-rim arterial-phase enhancement (85.2% vs. 68.5%; p = 0.024) and radiologically-evident cirrhosis (19.8% vs. 8.5%; p = 0.017) were more frequent in HBV-positive patients. Although RFS and OS did not significantly differ between the groups (p ≥ 0.327), the intrahepatic recurrence rate was significantly higher in the HBV-positive group (37.0% vs. 23.1%; p = 0.029). HBV positivity was also identified as an independent predictor of intrahepatic recurrence (odds ratio, 1.93; p = 0.047).
ConclusionHBV-associated ICCA demonstrates distinct MRI features and is associated with a higher rate of intrahepatic recurrence following curative resection.